FY2025 Q3 cumulative results (Nine months ended December 2025): Revenue 499.3B yen (YoY +2.2%), Operating Income 87.7B yen (+7.2%), Ordinary Income 101.7B yen (+14.3%), Net Income 69.7B yen (+14.3%). The company achieved profit growth exceeding revenue growth, driven by improved operating margin to 17.6% (from 16.7% prior year) through factory cost reductions of approximately 23B yen and pricing/product renewal initiatives contributing 14.8B yen. European subsidiaries demonstrated strong performance with operating income surging 59.6% YoY, offsetting weakness in Asian markets affected by economic slowdowns in China and Taiwan. Non-operating income expanded significantly due to foreign exchange gains of 528M yen, interest and dividend income totaling 744M yen, partially offset by reduced derivative losses. Total Assets reached 1,488.0B yen with Equity of 1,307.8B yen, maintaining a conservative balance sheet with cash and deposits of 487.9B yen and investment securities of 410.4B yen.
Revenue growth of 2.2% was driven by multiple factors across segments. The parent company (standalone) achieved 1.3% growth, with third quarter alone showing 3.0% increase as B2B2C products expanded 10.5% YoY. By customer segment, food manufacturers grew 3.7%, foodservice increased 1.9%, while convenience store channel declined 5.5% reflecting retail headwinds. Subsidiaries contributed 4.7% revenue growth (declining 1.3% on currency-neutral basis), with European operations up 14.3% (4.4% currency-neutral) compensating for Asia's 1.9% decline (5.4% currency-neutral).
Operating profit increased 7.2%, outpacing revenue growth due to margin expansion of 0.9 percentage points. This improvement stemmed from factory cost reduction initiatives achieving 23B yen (114% of 20B yen annual target) and operational profit improvements of 14.8B yen (97% of 15B yen target) through pricing adjustments and product renewals. Subsidiaries demonstrated even stronger operating leverage with 11.2% profit growth despite modest revenue increases, particularly in Europe where French operations achieved 1,037% operating income growth and Belgian operations improved 80.6%.
Ordinary income surged 14.3%, significantly exceeding operating income growth rate. The 14.0B yen gap between ordinary income (101.7B yen) and operating income (87.7B yen) reflects robust non-operating income totaling 14.9B yen, comprising interest income 516M yen, dividend income 228M yen, foreign exchange gains 528M yen, and equity method investment gains. This represents increased contribution from financial assets and favorable currency movements compared to prior year.
Net income grew 14.3% in line with ordinary income, indicating no material extraordinary items below the ordinary income line. The effective tax rate of approximately 31.0% remained stable, with income taxes of 31.3B yen on pre-tax profit of 101.0B yen.
Pattern conclusion: Revenue up/Profit up with strong operating leverage - operating margin improved 0.9 points to 17.6%, demonstrating successful cost management and pricing power despite modest top-line growth in a challenging demand environment.
The company operates primarily through its parent company (standalone) operations and overseas subsidiaries across Asia and Europe.
Parent Company (Standalone): Revenue 368.1B yen (YoY +1.3%), Operating Income 61.7B yen (+5.7%), representing the core business with 73.7% of consolidated revenue. Operating margin improved to 16.8% from 16.1% prior year. The third quarter alone showed accelerating growth at 3.0% driven by B2B2C product expansion (+10.5%), food manufacturer sales (+3.7%), and foodservice recovery (+1.9%). Convenience store channel weakness (-5.5%) reflected broader retail industry challenges. This segment's operating profit growth of 5.7% exceeded revenue growth through factory cost reductions achieving 114% of plan and operational improvements reaching 97% of target.
Subsidiary Operations Total: Revenue 131.2B yen (YoY +4.7%, currency-neutral -1.3%), Operating Income 25.9B yen (+11.2%, currency-neutral +4.9%), representing 26.3% of consolidated revenue. Operating margin expanded significantly to 19.8% from 18.6%, demonstrating strong operational leverage. The geographic mix shift with European strength offsetting Asian weakness drove profitability improvement.
Asian Subsidiaries: Revenue 70.4B yen (YoY -1.9%, currency-neutral -5.4%), Operating Income 17.1B yen (-2.6%, currency-neutral -6.7%). Operating margin compressed slightly despite representing the more mature subsidiary operations. China and Taiwan experienced consumption slowdowns, while Indonesian operations showed strength in both domestic and Japan-export markets, launching halal-certified ramen soup exports to Japan in January 2026.
European Subsidiaries: Revenue 58.5B yen (YoY +14.3%, currency-neutral +4.4%), Operating Income 8.9B yen (+59.6%, currency-neutral +45.9%). Operating margin surged to 15.2% from 10.5%, representing the strongest segment performance. French operations benefited from increased exports to Japan with operating income rising 1,037%, while Belgian operations achieved 80.6% profit growth, transitioning from operating losses toward full-year profitability. Netherlands operations also contributed to growth. Strategic initiatives including B2C expansion, UHT product launches, and Ariake-branded retail presence drove results.
Japanese Subsidiary: Revenue 2.3B yen (YoY -1.6%), Operating Income 0.1B yen (flat), representing minimal contribution.
The core parent company business drove overall revenue growth while European subsidiaries provided the strongest profit contribution on margin expansion, offsetting Asian market challenges. The company's strategy to expand B2B2C products and strengthen European operations is yielding measurable results.
Profitability: ROE 5.3% (calculated from net income margin 13.8% × asset turnover 0.336 × financial leverage 1.14), Operating Margin 17.6% (prior year 16.7%, +0.9pt), Net Profit Margin 13.8%. The ROE level reflects conservative capital structure with substantial cash and securities holdings rather than profitability issues, as operating margin ranks among industry leaders.
Cash Quality: Operating cash flow data not disclosed in quarterly materials. Cash and deposits of 487.9B yen represent 32.8% of total assets, indicating substantial liquidity reserves.
Investment: Capital expenditures totaled 16.8B yen on consolidated basis (12.6B yen standalone) for nine months, progressing in line with annual plans. Depreciation data not separately disclosed. R&D expenses totaled 3.9B yen (0.8% of revenue), reflecting the company's focus on natural seasoning product development and manufacturing process improvements.
Financial Health: Equity Ratio 87.9% (1,307.8B yen equity / 1,488.0B yen total assets), Current Ratio 688.5% (787.5B yen current assets / 114.4B yen current liabilities), demonstrating exceptionally strong solvency. Total liabilities of only 180.2B yen represent conservative leverage with debt-to-equity ratio of 0.14x. Net cash position substantial with no material interest-bearing debt disclosed.
Asset Efficiency: Total asset turnover 0.336x (annualized revenue 665.7B yen / total assets 1,488.0B yen), indicating room for improvement in capital efficiency. Accounts receivable increased 28.2% to 164.1B yen while revenue grew only 2.2%, resulting in DSO extending to approximately 120 days and signaling collection cycle elongation. Inventory levels also elevated, contributing to extended operating cycle.
Operating CF: Detailed cash flow statement not disclosed in quarterly XBRL data. However, the substantial cash balance of 487.9B yen (up from prior period levels) combined with strong net income of 69.7B yen suggests cash generation capability remains intact. The concern centers on working capital dynamics, as accounts receivable surged 36.1B yen (+28.2%) and inventory levels remain elevated with days inventory outstanding of 136 days, significantly above industry norms. These working capital increases likely absorbed material operating cash flow during the period.
Investing CF: Investment securities increased 80.5B yen to 410.4B yen, representing significant capital deployment in financial assets generating 744M yen in interest and dividend income. Capital expenditures of 16.8B yen consolidated (12.6B yen standalone) for nine months remain moderate relative to depreciation, focused on maintenance and incremental capacity. The U.S. subsidiary establishment with 10M USD capital commitment and plant site evaluation represents future investment pipeline, though timing remains under review due to elevated construction costs.
Financing CF: Annual dividend guidance of 120 yen per share (interim 20 yen, year-end 110 yen) implies approximately 38.3B yen total dividends based on shares outstanding. No share buyback programs disclosed. The dividend payout ratio of approximately 61.9% (calculated from full-year guidance) represents substantial cash return to shareholders.
FCF: Free cash flow calculation limited by lack of operating CF disclosure, but the combination of strong net income, moderate capex, and stable cash balances suggests positive free cash flow generation before working capital headwinds. The extended receivables and inventory cycles warrant monitoring as they represent cash conversion headwinds.
Cash generation: Adequate - Strong profitability and conservative balance sheet provide cushion, but working capital deterioration (receivables +28.2%, elevated inventory days) creates cash cycle concerns requiring management attention. The substantial cash and securities holdings of 898.3B yen (60.4% of total assets) provide significant buffer for dividend payments and strategic investments, though optimal capital allocation efficiency remains questionable.
Ordinary vs Net Income: Ordinary income of 101.7B yen exceeded operating income of 87.7B yen by 14.0B yen (15.9% premium), reflecting substantial non-operating income. Key components include interest income 516M yen, dividend income 228M yen, foreign exchange gains 528M yen, and equity method investment income. The foreign exchange gain represents a potentially volatile element tied to yen movements against euro, dollar, and Asian currencies, though management employs derivative hedging. The derivative valuation loss decreased significantly from prior year, contributing to the non-operating income improvement. While currency impacts warrant monitoring, the 7.7B yen in interest and dividend income from securities holdings represents more sustainable non-operating contribution.
Non-recurring items: No material extraordinary gains or losses, impairment charges, restructuring costs, or asset sale gains identified in the period. The earnings quality appears clean with no significant one-time adjustments.
Accruals concern: The substantial accounts receivable increase (+36.1B yen, +28.2%) against modest revenue growth (+2.2%) raises earnings quality flags. This disconnect suggests either extended payment terms, collection challenges, or year-end timing effects. The DSO deterioration to 120 days (significantly above the food & beverage industry median of 71 days) indicates cash conversion is lagging reported revenues. Similarly, inventory days of 136 days far exceed industry median of 51 days, suggesting potential obsolescence risk or production cycle mismatches. These working capital trends, if sustained, would signal that reported profits are not fully converting to cash, representing a quality concern. However, the company's strong cash position and historically conservative management mitigate near-term risks.
Overall assessment: Core operating earnings quality is solid with 17.6% operating margin demonstrating genuine profitability. The non-operating income contribution is material but largely recurring (interest, dividends) with currency gains representing the volatile component. The primary earnings quality concern centers on working capital management rather than profit recognition, as extended receivables and inventory cycles suggest cash realization is lagging accounting profits.
Full-year guidance: Revenue 671.0B yen (YoY +2.6%), Operating Income 122.2B yen (+9.9%), Ordinary Income 129.0B yen (+7.5%), Net Income 87.0B yen (+6.8%). No revisions announced from initial forecasts.
Progress rate analysis (Q3 cumulative vs full-year guidance): Revenue 74.4% (499.3B / 671.0B), Operating Income 71.8% (87.7B / 122.2B), Ordinary Income 78.8% (101.7B / 129.0B), Net Income 80.1% (69.7B / 87.0B). With nine months representing 75.0% of the year, revenue and operating income progress rates trail slightly at -0.6pt and -3.2pt respectively, while ordinary and net income exceed standard progression by +3.8pt and +5.1pt.
The below-standard operating income progress suggests Q4 requires 34.5B yen operating income versus 29.2B yen in Q4 prior year (+18.2% YoY), representing acceleration from the nine-month growth rate of 7.2%. Management commentary indicates confidence in achieving targets through: (1) parent company Q4 revenue growth of 2.5-3.5% driven by B2B2C product expansion and convenience store recovery, (2) continued European subsidiary strength offsetting Asian market weakness, and (3) ongoing cost reduction and operational improvement initiatives. However, the revenue guidance appears challenging given CVS channel weakness persisting and Asian market headwinds, suggesting potential operating income margin compression risk in Q4 or modest guidance shortfall.
The ahead-of-schedule ordinary and net income progression reflects stronger-than-planned non-operating income, particularly foreign exchange gains and reduced derivative losses. This over-performance may not fully recur in Q4 if currency movements reverse, creating potential downside to full-year ordinary income guidance despite operating income line visibility.
Key variables for guidance achievement: (1) Q4 parent company revenue acceleration materializing through B2B2C adoption and CVS recovery, (2) European profitability sustaining despite elevated euro increasing input costs, (3) Asian markets stabilizing from current weakness, and (4) currency rates remaining supportive (euro at 174.47 yen in Q3 versus full-year assumption of 167.0 yen implies potential headwind if sustained).
Dividend policy: Annual dividend of 120 yen per share for FY2025 (interim 20 yen paid, year-end 110 yen planned), unchanged from prior guidance. Based on full-year net income guidance of 87.0B yen and approximately 31.86M shares outstanding (calculated from basic EPS guidance of 273.17), total dividends approximate 38.2B yen, representing a payout ratio of 43.9%. However, using actual nine-month net income of 69.7B yen annualized suggests potential payout ratio of approximately 61.9% if full-year earnings undershoot guidance, as noted in XBRL analysis.
Sustainability assessment: The dividend payment of 38-39B yen is well-covered by cash and deposits of 487.9B yen and investment securities of 410.4B yen, providing over 23x coverage of annual dividend from liquid assets alone. Even at the higher 61.9% payout scenario, near-term sustainability is not questioned given the fortress balance sheet. The concern centers on long-term strategic capital allocation efficiency - holding nearly 900B yen in cash and securities (60% of total assets) while paying modest dividends suggests room for enhanced shareholder returns through increased dividends, share buybacks, or growth investments. Management's conservative approach prioritizes financial stability and strategic optionality (such as the planned U.S. expansion) over maximizing current returns.
Share buybacks: No share repurchase programs disclosed or announced for the current fiscal year. The absence of buybacks despite substantial excess cash and modest payout ratio represents a potential opportunity for enhanced capital efficiency.
Total shareholder return: Limited to dividends only (payout ratio 43.9% per guidance), with no buyback component. The total return ratio equals the dividend payout ratio in absence of repurchases.
Historical context: The company maintains consistent dividend policy with gradual increases aligned with earnings growth, reflecting management's preference for stability over payout ratio targeting. The current 120 yen dividend represents continuation of this steady approach.
Near-term:
Long-term:
Industry Position (Reference - Proprietary Analysis)
Profitability: Operating Margin 17.6% vs. Industry Median 4.9% (Q3 2025, 13 companies), positioning in the top tier of the food & beverage sector. The company's 17.6% operating margin significantly exceeds the industry interquartile range of 3.4%-7.1%, reflecting premium positioning in natural seasoning ingredients with high barriers to entry. Net Profit Margin 13.8% vs. Industry Median 3.4% (IQR: 2.8%-5.5%), similarly demonstrating superior profitability. ROE 5.3% vs. Industry Median 5.2%, placing near industry median despite strong profit margins, due to exceptionally conservative balance sheet with 87.9% equity ratio and substantial cash holdings diluting return metrics.
Efficiency: Asset Turnover 0.336x vs. Industry Median 0.61x (Q3 2025), indicating significant underperformance in capital efficiency. The company's asset base inflated by cash/securities of 898.3B yen (60% of assets) and extended working capital cycles suppresses turnover metrics. Receivables Turnover 120 days (estimated) vs. Industry Median 71 days (IQR: 59-102 days), flagging collection cycle deterioration. Inventory Turnover 136 days vs. Industry Median 51 days (IQR: 36-85 days), substantially elevated reflecting either production cycle requirements for natural fermentation processes or inventory management inefficiency. Operating Working Capital Turnover 197 days (CCC estimate) vs. Industry Median 62 days (IQR: 44-96 days), representing the most significant efficiency gap requiring management attention.
Growth: Revenue Growth 2.2% vs. Industry Median 3.8% (IQR: 0.6%-5.1%), positioning below median but within normal range. EPS Growth 14.6% vs. Industry Median 16% (IQR: -9%-46%), demonstrating solid profit growth despite modest revenue expansion.
Financial Health: Equity Ratio 87.9% vs. Industry Median 48.0% (IQR: 44.7%-61.3%), representing exceptionally conservative capitalization far exceeding industry norms. Current Ratio 688.5% vs. Industry Median 176% (IQR: 141%-238%), indicating substantial excess liquidity. Net Debt/EBITDA not meaningful as company maintains net cash position, compared to industry median of -0.51x (IQR: -3.65 to 1.26), positioning among the strongest balance sheets in the sector.
Industry: Food & Beverage Manufacturing (13 companies), Comparison period: Q3 2025 fiscal periods, Source: Proprietary analysis of publicly disclosed financial data
Assessment: Ariake Japan demonstrates best-in-class profitability metrics reflecting its specialized natural seasoning ingredient niche with strong pricing power and operational excellence. However, capital efficiency metrics significantly lag industry standards due to conservative cash management and working capital cycle challenges. The company operates with fortress balance sheet strength but at the cost of return on capital metrics. The strategic priority should center on working capital optimization and productive deployment of excess cash to improve asset turnover and ROE toward levels commensurate with the exceptional operating margins achieved.
Working Capital Deterioration Risk (High): Accounts receivable surged 36.1B yen (+28.2%) to 164.1B yen while revenue grew only 2.2%, extending DSO to approximately 120 days versus industry median of 71 days, representing a 69% premium to peer collection cycles. Inventory days of 136 days exceed industry median of 51 days by 167%, resulting in cash conversion cycle of 197 days versus industry median of 62 days. This 135-day extension ties up substantial capital and creates vulnerability to demand shocks or customer credit deterioration. If the trend continues, operating cash flow generation could materially decline despite strong reported profitability, constraining dividend sustainability and growth investment capacity beyond 2-3 years. Immediate management action required on credit terms enforcement and inventory optimization to prevent further deterioration.
Geographic Concentration and Asian Market Exposure Risk (Medium-High): Asian subsidiaries representing 53.7% of overseas revenue declined 1.9% (5.4% currency-neutral) due to consumption weakness in China and Taiwan, two significant markets. With Chinese economic slowdown potentially persistent and geopolitical tensions affecting business sentiment, the 70.4B yen Asian revenue base faces ongoing pressure. The 17.1B yen operating income from Asia (declining 2.6%) demonstrates margin compression risk if volumes continue falling. While European strength partially offsets this exposure, the company lacks material presence in other growth markets. Indonesian operations provide partial mitigation through halal product exports to Japan, but scale remains limited. Prolonged Asian market weakness could reduce group profitability by an estimated 5-8% if Asia operating income declines 20-30% from current levels.
Currency and Input Cost Volatility Risk (Medium): The euro reached 174.47 yen in Q3 versus full-year assumption of 167.0 yen, representing 4.5% adverse variance that increases European input costs and Japanese import prices from French operations. A 5 yen sustained euro strengthening could reduce consolidated operating margin by an estimated 0.3-0.5 percentage points based on European operations scale. Additionally, natural ingredient sourcing for seasoning production exposes the company to agricultural commodity price volatility and weather-related supply disruptions. While the company demonstrates pricing power to pass through cost increases (evidenced by 14.8B yen operational profit improvement through pricing and renewals), timing lags between input cost increases and customer price adjustments can compress margins for 2-4 quarters. The 528M yen foreign exchange gain in Q3 demonstrates earnings volatility from currency, though derivative hedging provides partial mitigation.
Profitability Excellence with Capital Efficiency Gap: Operating margin of 17.6% positions more than 3.5x industry median of 4.9%, demonstrating sustainable competitive advantages in natural seasoning ingredients through proprietary fermentation technology, quality reputation, and customer switching costs. Factory cost reduction achieving 114% of annual target (23B yen vs 20B yen plan) and operational profit improvement reaching 97% of target (14.8B yen vs 15B yen plan) validates management execution capability. However, ROE of 5.3% near industry median of 5.2% despite vastly superior operating margins reveals capital allocation inefficiency - the company holds 898.3B yen in cash and securities (60% of total assets) generating minimal returns while asset turnover of 0.336x significantly trails industry median of 0.61x. The strategic implication centers on working capital optimization as immediate priority (targeting DSO reduction from 120 to sub-90 days and DIO improvement from 136 to sub-100 days could release 30-50B yen cash) and evaluation of accelerated shareholder returns or growth investments to productively deploy excess capital and improve ROIC toward levels justified by the 17.6% operating margins achieved.
European Pivot Success Creating Geographic Rebalancing Opportunity: European subsidiary operating income surged 59.6% to 8.9B yen with margin expansion to 15.2% from 10.5%, driven by French operations achieving 1,037% profit growth on Japan export volumes and Belgian turnaround progressing to near-breakeven from losses. Europe now contributes 34.4% of subsidiary operating income despite representing 44.6% of subsidiary revenue, demonstrating superior profitability trajectory. This success partially offsets Asian market weakness (China and Taiwan declining 5.4% currency-neutral) and validates management's strategy to diversify away from Asia concentration. The B2C product expansion in Europe with dedicated management resources, Ariake-branded retail presence, and Metoro ramen soup launches positions for consumer market penetration beyond traditional B2B foodservice base. Combined with Indonesia halal-certified product exports to Japan starting January 2026, the geographic and channel diversification reduces business model risk. The planned U.S. plant investment, though delayed by construction cost concerns, represents logical next phase of global footprint expansion to serve North American market directly rather than through imports, though execution timeline and return hurdles require clarity.
Working Capital Deterioration Demands Management Focus Despite Strong Liquidity: The 28.2% accounts receivable increase against 2.2% revenue growth, extending DSO to 120 days (69% above industry median), combined with inventory days of 136 days (167% above industry median) creating cash conversion cycle of 197 days versus industry median of 62 days represents the most significant operational concern. This 135-day working capital penalty ties up an estimated 70-90B yen excess capital and signals potential issues with customer credit terms, collection enforcement, or demand forecasting accuracy. While the 487.9B yen cash balance and minimal debt provide near-term comfort for the 38-39B yen annual dividend, continuation of working capital deterioration would eventually constrain cash generation despite strong reported earnings. The disconnect between 13.8% net margin and 5.3% ROE stems significantly from this capital intensity. Management must demonstrate tangible working capital improvement in Q4 and FY2026 through shortened collection cycles, inventory optimization, and enhanced cash conversion to validate that the operational excellence demonstrated in margin expansion translates to cash returns. Failure to address working capital efficiency would justify valuation discounts despite premium profitability metrics, as capital-intensive business models warrant lower multiples than capital-efficient peers.
This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI analysis of PDF earnings presentation
For Ariake Japan’s FY2026/3 Q3, consolidated net sales were 499.3億円 (YoY +2.2%), operating income 87.7億円 (+7.2%), and net income 68.9億円 (+14.6%), achieving higher sales and earnings. Even on a currency-neutral basis, the company secured growth in both revenue and profit. On a standalone basis, net sales were 368.1億円 (+1.3%) and operating income 61.7億円 (+5.7%). In Q3 alone, sales were up +3.0% YoY with B2B2C products expanding. Subsidiaries posted lower sales on a currency-neutral basis but higher profits (net sales +4.7%, operating income +11.2%), with strong performance in Europe offsetting weakness in Asia’s sluggish economy. Full-year guidance remains unchanged at net sales of 671億円 and operating income of 122億円.
Consolidated operating margin remained elevated at 17.6% (up +0.9ppt from 16.7% a year earlier). European subsidiaries delivered a sharp profit increase (France operating income up 1037%, Belgium up 80.6%), offsetting weak performance in Asia. Standalone factory cost reductions achieved approximately 23億円 (114%) versus the plan of about 20億円 per year. Ordinary income rose significantly by +14.3% YoY due to higher dividend income, foreign exchange gains, and reduced derivative valuation losses. Exports to Japan of halal-certified ramen soup from the Indonesia plant commenced in January 2026.
Full-year guidance remains unchanged at net sales of 671億円 and operating income of 122億円 (operating margin 18.2%). On a standalone basis, the company aims to drive sales growth through continued adoption of B2B2C products for distribution, recovery in the CVS channel, and enhancements to existing products. Q4 sales are expected to be +2.5–3.5% YoY. Subsidiaries aim to achieve plan by offsetting Asia’s weakness with higher sales and earnings in Europe. While a stronger-than-assumed euro could push up costs, factory cost reductions and profit improvement in sales (price revisions and renewals) will continue.
Management explicitly stated: “We will offset Asia’s weakness with Europe and achieve the plan through standalone sales growth in the second half.” On a standalone basis, operating margin improved with sales growth: 1Q 16.2%, 2Q 14.9%, 3Q 18.8%. Profit improvement in sales (price revisions and renewals) achieved 14.8億円 (97%) against the annual plan of 15億円. While sales growth is expected to come in slightly below plan, both operating income and operating margin are also projected to finish only slightly below plan.
Strengthen expansion of B2B2C products: Increase adoption of new products for CVS and mass retailers and bolster promotional activities; on a standalone basis, the cumulative Q3 sales mix reached 11.9% (YoY +10.5%). Expand B2C and UHT products in Europe: Hired a B2C manager in Belgium; launched three ramen soup varieties at Metro in France; installed dedicated Ariake shelves. Expand halal-certified products: Began exports to Japan of halal-certified ramen soup (soy sauce, miso, and tantanmen) from the Indonesia plant. Drive profit improvement at European plants: In France and Belgium, absorb fixed costs through higher production and improve utility costs; Belgium is expected to be profitable for the full year. Advance establishment of U.S. subsidiary: Established Ariake U.S.A. Inc. in July 2024 (capital: 1,000万ドル); selected a prospective site in Virginia on the East Coast but are reviewing the business plan due to surging construction costs.
Sales decline to the CVS channel: Due to weak CVS sales, standalone cumulative Q3 was -5.5% YoY and also below plan. Economic slowdown at Asian subsidiaries: Ongoing consumption weakness in China and Taiwan, with China -1.9% YoY (currency-neutral -5.4%) and Taiwan -1.9% (same -5.4%). Cost inflation from euro appreciation: Stronger-than-assumed euro (EUR 174.47円) may raise raw material and import costs going forward. Concerns over accounts receivable collection: The increase in receivables flagged as DSO 120 days in XBRL analysis corresponds to a sharp rise in standalone receivables from 128.01億円 to 164.11億円 (+28.2%) despite standalone sales up only +1.3% YoY; this was also confirmed in the PDF materials. Delay in the new U.S. plant plan: Reviewing the business plan due to soaring construction and equipment costs, making the investment timing uncertain.